⌘K

Login Start Free

Home/Filings/4/0001062993-24-001418

4//SEC Filing

Lefebvre Eric 4

Accession 0001062993-24-001418

CIK 0001042074other

View on SEC.gov Company Profile

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 6:16 PM ET

Size

5.4 KB

Accession

0001062993-24-001418

Insider Transaction Report

Form 4

Period: 2024-01-24

CymaBay Therapeutics, Inc.CBAY

Director

Transactions

Award
Stock Option (right to buy)
2024-01-24+14,010→ 14,010 total
Exercise: $22.85Exp: 2034-01-23→ Common Stock (14,010 underlying)

Footnotes (1)

[F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2024.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1

filerCIK 0001614741

Filing Metadata

Form type: 4
Filed: Jan 25, 7:00 PM ET
Accepted: Jan 26, 6:16 PM ET
Size: 5.4 KB

View on SEC.gov